UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

Filed by the Registrant  x                            Filed by a Party other than the Registrant  ¨

Check the appropriate box:

¨ Preliminary Proxy Statement

¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

¨ Definitive Proxy Statement

x Definitive Additional Materials

¨ Soliciting Material Pursuant to §240.14a-12

BIOJECT MEDICAL TECHNOLOGIES, INC.

(Exact Name of Registrant as Specified In Its Charter)

Payment of Filing Fee (Check the appropriate box):

x No fee required

¨ Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11

1) Title of each class of securities to which transaction applies:

2) Aggregate number of securities to which transaction applies:

3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):

4) Proposed maximum aggregate value of transaction:

5) Total fee paid:

¨ Fee paid previously with preliminary materials.

¨ Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

1) Amount Previously Paid:

2) Form, Schedule or Registration Statement No.:

3) Filing Party:

4) Date Filed:

*** Exercise Your Right to Vote ***

Important Notice Regarding the Availability of Proxy Materials for the

Shareholder Meeting to Be Held on June 10, 2010

			Meeting Information
	BIOJECT MEDICAL TECHNOLOGIES INC.		Meeting Type:    Annual Meeting
			For holders as of:    April 13, 2010
			Date: June 10, 2010                Time:  9:00 AM PDT
			Location: 20245 S.W. 95th Avenue
			Tualatin, Oregon 97062
	BROKER LOGO HERE
	Return Address Line 1
	Return Address Line 2 Return Address Line 3 51 MERCEDES WAY EDGEWOOD NY 11717		You are receiving this communication because you hold shares in the above named company.
	Investor Address Line 1 Investor Address Line 2 Investor Address Line 3 Investor Address Line 4 Investor Address Line 5 John Sample 1234 ANYWHERE STREET ANY CITY, ON A1A 1A1		This is not a ballot. You cannot use this notice to vote these shares. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. You may view the proxy materials online at www.proxyvote.com or easily request a paper copy (see reverse side). We encourage you to access and review all of the important information contained in the proxy materials before voting.
			See the reverse side of this notice to obtain proxy materials and voting instructions.

— Before You Vote —

How to Access the Proxy Materials

Proxy Materials Available to VIEW or RECEIVE: 1. Combined Document How to View Online: Have the 12-Digit Control Number available (located on the following page) and visit: www.proxyvote.com. How to Request and Receive a PAPER or E-MAIL Copy: If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for requesting a copy. Please choose one of the following methods to make your request:
1) BY INTERNET:	www.proxyvote.com
2) BY TELEPHONE:	1-800-579-1639
3) BY E-MAIL*:	sendmaterial@proxyvote.com
*  If requesting materials by e-mail, please send a blank e-mail with the 12-Digit Control Number (located on the following page) in the subject line.
Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to your investment advisor. Please make the request as instructed above on or before May 27, 2010 to facilitate timely delivery.

— How To Vote —

Please Choose One of the Following Voting Methods

	Vote In Person: If you choose to vote these shares in person at the meeting, you must request a “legal proxy.” To do so, please follow the instructions at www.proxyvote.com or request a paper copy of the materials, which will contain the appropriate instructions. Many shareholder meetings have attendance requirements including, but not limited to, the possession of an attendance ticket issued by the entity holding the meeting. Please check the meeting materials for any special requirements for meeting attendance.
	Vote By Internet: To vote now by Internet, go to www.proxyvote.com. Have the 12-Digit Control Number available and follow the instructions.
	Vote By Mail: You can vote by mail by requesting a paper copy of the materials, which will include a voting instruction form.

Voting items
The Board of Directors recommends that you vote For the following:
1.	Election of Directors
	Nominees
01	David Tierney, M.D.	02    Edward L. Flynn	03    Al Hansen	04    Mark Logomasini
The Board of Directors recommends you vote FOR the following proposal(s):
2	To amend the Company’s 1992 Stock Incentive Plan (the “Plan”) to increase the number of shares available for issuance under the Plan and to extend the expiration date of the Plan.
3	To amend Article IX and delete Article X of the Company’s 2002 Amended and Restated Articles of Incorporation to declassify the Company’s Board of Directors and eliminate a 75% shareholder voting requirement for certain matters.
4	To amend the Company’s 2002 Amended and Restated Articles of Incorporation to increase the number of authorized shares of preferred stock.
NOTE:	To transact such other business as may properly come before the Annual Meeting or any adjournments of the meeting.

	g	0000 0000 0000

			Reserved for Broadridge Internal Control Information
		Voting Instructions
	THIS SPACE RESERVED FOR LANGUAGE PERTAINING TO
	BANKS AND BROKERS
	AS REQUIRED BY THE NEW YORK STOCK EXCHANGE
	THIS SPACE RESERVED FOR SIGNATURES IF APPLICABLE